Abiopharma

QUANTERIX CORP (QTRX)

Symbol	QTRX
Name	QUANTERIX CORP
Sector	INDUSTRIALS
Region	North America
Industry	Laboratory Analytical Instruments
Address	900 MIDDLESEX TURNPIKE, BILLERICA, MA 01821
Telephone	617-301-9400
Fax	—
Email	—
Website	https://www.quanterix.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001503274
Description	Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability. Additional info from NASDAQ: Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability.

2026-08-19 10:37

DONNELLY WILLIAM P 🟡 adjusted position in 0 shares (1 derivative) of Quanterix Corp (QTRX) Transaction Date: Aug 17, 2026 | Filing ID: 000009

2026-08-19 07:38

New Form 3 - Quanterix Corp Filed: 2026-08-19 AccNo: 0002148276-26-000001 Size: 6 KB

2026-08-17 20:14

Miller Michael Francis 🟡 adjusted position in 467 shares (5 derivative) of Quanterix Corp (QTRX) at $2.59 Transaction Date: Aug 15, 2026 | Filing ID: 000015

2026-08-14 20:01

DONNELLY WILLIAM P 🟢 acquired 99.4K shares of Quanterix Corp (QTRX) at $2.93 Transaction Date: Aug 12, 2026 | Filing ID: 000008

2026-08-14 16:16

New Form SCHEDULE 13G/A - Quanterix Corp Filed: 2026-08-14 AccNo: 0001104659-26-096972 Size: 9 KB

2026-08-10 12:07

(30% Negative) QUANTERIX CORP (QTRX) Reports Q3 2026 Financial Results

2026-08-10 12:01

Quanterix Names Jim Gute Chief Commercial Officer

2026-08-10 12:00

Quanterix Releases Financial Results for the Second Quarter of 2026

2026-08-06 12:00

Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12

2026-08-04 12:00

Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026